ATE163410T1 - Beta-oxo-beta-benzenepropanthioamidderivate - Google Patents

Beta-oxo-beta-benzenepropanthioamidderivate

Info

Publication number
ATE163410T1
ATE163410T1 AT92121020T AT92121020T ATE163410T1 AT E163410 T1 ATE163410 T1 AT E163410T1 AT 92121020 T AT92121020 T AT 92121020T AT 92121020 T AT92121020 T AT 92121020T AT E163410 T1 ATE163410 T1 AT E163410T1
Authority
AT
Austria
Prior art keywords
group
beta
hydrogen atom
alkyl
atom
Prior art date
Application number
AT92121020T
Other languages
English (en)
Inventor
Tetsuo Sekiya
Mikio Tsutsui
Tetsuro Shimpuku
Tatsuo Nagano
Junko Hayashi
Asami Seino
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE163410T1 publication Critical patent/ATE163410T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/02Monothiocarboxylic acids
    • C07C327/04Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/12Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/38Amides of thiocarboxylic acids
    • C07C327/46Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/38Amides of thiocarboxylic acids
    • C07C327/40Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92121020T 1991-12-26 1992-12-09 Beta-oxo-beta-benzenepropanthioamidderivate ATE163410T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34565791 1991-12-26

Publications (1)

Publication Number Publication Date
ATE163410T1 true ATE163410T1 (de) 1998-03-15

Family

ID=18378084

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92121020T ATE163410T1 (de) 1991-12-26 1992-12-09 Beta-oxo-beta-benzenepropanthioamidderivate

Country Status (11)

Country Link
US (2) US5332833A (de)
EP (1) EP0548680B1 (de)
JP (1) JP2707936B2 (de)
KR (1) KR930012698A (de)
AT (1) ATE163410T1 (de)
CA (1) CA2086210A1 (de)
DE (1) DE69224507T2 (de)
DK (1) DK0548680T3 (de)
ES (1) ES2113399T3 (de)
GR (1) GR3026240T3 (de)
TW (1) TW242138B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0548680B1 (de) * 1991-12-26 1998-02-25 Mitsubishi Chemical Corporation Beta-Oxo-Beta-Benzenepropanthioamidderivate
WO1996022086A1 (fr) * 1995-01-17 1996-07-25 Mitsubishi Chemical Corporation MEDICAMENT CONTENANT UN DERIVE DE β-OXO-β-BENZENEPROPANE-THIOAMIDE
CN1162151C (zh) * 1998-01-14 2004-08-18 日本新药株式会社 钾通道激活剂
JP4073786B2 (ja) * 2001-04-16 2008-04-09 田辺三菱製薬株式会社 高コンダクタンス型カルシウム感受性kチャネル開口薬
EP1465869B1 (de) 2001-12-21 2013-05-15 Exelixis Patent Company LLC Modulatoren von lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
DK1928454T3 (da) 2005-05-10 2014-11-03 Intermune Inc Pyridonderivater til modulering af stress-aktiveret proteinkinasesystem
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン, インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
WO2016144936A1 (en) 2015-03-09 2016-09-15 Bristol-Myers Squibb Company Lactams as inhibitors of rock
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460909C2 (de) * 1974-12-21 1986-02-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von alpha- Oxothiodimethylamiden
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US4299845A (en) * 1980-04-14 1981-11-10 Schering Corporation Dermatological compositions and methods of use therefor
GB8530015D0 (en) * 1985-12-05 1986-01-15 Ici Plc Biologically active amide derivatives
US4851526A (en) * 1987-09-04 1989-07-25 Schering A.G. 1-(4-Substituted phenyl)-1H-imidazoles compounds
US5185375A (en) * 1987-12-18 1993-02-09 May & Baker Limited Thioformamide derivatives
EP0548680B1 (de) * 1991-12-26 1998-02-25 Mitsubishi Chemical Corporation Beta-Oxo-Beta-Benzenepropanthioamidderivate

Also Published As

Publication number Publication date
US5332833A (en) 1994-07-26
EP0548680B1 (de) 1998-02-25
US5439927A (en) 1995-08-08
DK0548680T3 (da) 1998-09-23
ES2113399T3 (es) 1998-05-01
KR930012698A (ko) 1993-07-21
DE69224507T2 (de) 1998-08-20
JP2707936B2 (ja) 1998-02-04
GR3026240T3 (en) 1998-05-29
CA2086210A1 (en) 1993-06-27
DE69224507D1 (de) 1998-04-02
TW242138B (de) 1995-03-01
JPH05246980A (ja) 1993-09-24
EP0548680A1 (de) 1993-06-30

Similar Documents

Publication Publication Date Title
DE3677452D1 (de) Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FI892787A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
CA2119572A1 (en) Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
NO174711C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater
DE69224507D1 (de) Beta-Oxo-Beta-Benzenepropanthioamidderivate
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
KR940019701A (ko) N-헤테로아릴-n'-페닐우레아 유도체, 그의 제조방법 및 용도
FI943142A (fi) Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt
ATE140003T1 (de) 1,8-naphthyridin-2-on-derivate
NO975666L (no) Pyrrolderivater og medisinsk sammensetning
DE3773415D1 (de) Flavonkarbonsaeure-derivate.
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
TR199902495T2 (xx) Bile�imler.
ATE145906T1 (de) Benzamid-derivate
ATE18196T1 (de) 1,4-acyloxynaphthalenderivate, diese enthaltende kompositionen, verfahren fuer ihre herstellung und zwischenprodukte dafuer.
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
DE60027908D1 (de) Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung
NO161493C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,6-nafthyridinderivater.
EP0322153A3 (de) Heterozyklyl Oxophtalazynyl-Essigsäuren
RO115873B1 (ro) Derivaţi de acid hidroximic, procedee de obţinere a acestora, intermediari pentru realizarea unuia dintre procedee şi compoziţie farmaceutică
DE69130266D1 (de) Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel
DE69428206D1 (de) Chinolincarbonsäurederivate und ihre salze
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
ES2193168T3 (es) Nuevos derivados de acido parabanico como inhibidores de aldosa reductasa.
WO2003018564A1 (fr) Inhibiteur d'acat selectif de la paroi vasculaire

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee